Related Experiment Video
Updated: Aug 8, 2026

Human T Lymphocyte Isolation, Culture and Analysis of Migration In Vitro
Published on: June 2, 2010
Myeloid cells migrate in response to IL-24
Krisztina Buzas1, Joost J Oppenheim, O M Zack Howard
1Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, National Cancer Institute-Frederick, Center for Cancer Research, Frederick, MD 21702, USA.
Insights
Interleukin-24 (IL-24) promotes the migration of human immune cells, including monocytes and neutrophils. This cytokine activates signaling pathways, potentially contributing to its anti-cancer effects by attracting myeloid cells.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Interleukin-24 (IL-24), a member of the IL-10 cytokine family, exhibits anti-tumor activity.
- IL-24 is produced by immune tissues and its expression is inducible in human peripheral blood mononuclear cells.
- The specific response of immune cells to IL-24 remains largely uncharacterized.
Purpose of the Study:
- To investigate the chemotactic effects of IL-24 on human immune cells.
- To identify the signaling pathways and receptors involved in IL-24-induced immune cell migration.
Main Methods:
- Recombinant human IL-24 was used to stimulate human monocytes and neutrophils in vitro.
- An in vivo chemotaxis model was employed to assess IL-24's effect on myeloid cell attraction.
- Signaling pathway inhibitors (pertussis toxin, MEK, JAK inhibitors) were used to probe IL-24's mechanism of action.
Main Results:
- IL-24 demonstrated in vitro chemotactic activity, inducing migration of human monocytes and neutrophils.
- In vivo models confirmed that IL-24 attracts CD11b positive myeloid cells.
- IL-24-induced monocyte migration was significantly reduced by pertussis toxin, MEK, and JAK inhibitors, implicating G-protein coupled receptors and associated signaling cascades.
Conclusions:
- IL-24 elicits migration of myeloid cells through activation of multiple signaling cascades.
- These findings suggest a mechanism by which IL-24's anti-cancer properties may be mediated via immune cell recruitment.
Abstract:
IL-24 (melanoma differentiation associated gene 7 product) is a member of the IL-10 cytokine family that has been reported to possess anti-tumor activity. IL-24 is produced by immune tissues and its expression can be induced in human peripheral blood mononuclear cells by pathogen-associated molecules. While immune cells are known to produce IL-24, the response of immune cells to IL-24 is unclear. Using recombinant human IL-24, we demonstrated that IL-24 induces human monocyte and neutrophil migration, in vitro. An in vivo chemotaxis model showed that IL-24 attracted CD11b positive myeloid cells. To further characterize the chemotactic IL-24 response and type(s) of receptor(s) utilized by IL-24, we treated monocytes with signaling pathway inhibitors. IL-24-induced migration was reduced by pertussis toxin treatment, thus implicating G-protein coupled receptors in this process. Additionally, MEK and JAK inhibitors markedly decreased monocyte migration toward IL-24. These results suggest that IL-24 activates several signaling cascades in immune cells eliciting migration of myeloid cells, which may contribute to the known anti-cancer effects of IL-24.
Related Concept Videos
Cell Migration
Cell Migration
Chemotaxis and Direction of Cell Migration
Differentiation of Common Myeloid Progenitor Cells
Cells of the Adaptive Immune Response

